Published in
Nature Research, Nature Medicine, 2(29), p. 422-429, 2023
DOI: 10.1038/s41591-022-02182-7
Links
Tools
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Journal article published in 2023 by
Sham Mailankody 
,
Jeffrey V. Matous,
Saurabh Chhabra ,
Michaela Liedtke,
Surbhi Sidana ,
Olalekan O. Oluwole,
Shahbaz Malik,
Rajneesh Nath,
Faiz Anwer,
Jose Carlos Cruz,
Myo Htut,
Erin E. Karski,
Wade Lovelace,
Myles Dillon,
Eric Butz
and other authors.
,
Jeffrey V. Matous,
Saurabh Chhabra ,
Michaela Liedtke,
Surbhi Sidana ,
Olalekan O. Oluwole,
Shahbaz Malik,
Rajneesh Nath,
Faiz Anwer,
Jose Carlos Cruz,
Myo Htut,
Erin E. Karski,
Wade Lovelace,
Myles Dillon,
Eric Butz
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 